Observational studyBMC gastroenterology2026
Clinical profile and hepatocellular cancer treatment patterns in resource limited settings- a cross-sectional observational study at two tertiary referral teaching hospitals, Addis Ababa, Ethiopia.
Observational study in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatocellular carcinoma (HCC) imposes a high global burden. A significant treatment gap exists in low- and middle-income countries (LMICs), where low rates of curative surgical intervention highlight profound healthcare inequities.
objectiveTo evaluate the clinical profile and treatment patterns of HCC patients at TASH and SPHMMC Addis Ababa, Ethiopia.
methodsThis hospital-based cross-sectional observational study included 130 HCC patients. Continuous variables were assessed for normality using the Shapiro-Wilk test and described using means and ± SD, while medians and IQR used for skewed data.
resultsThe mean age was 54.5 ± 16.5 years with a 63.1% male predominance. Although viral hepatitis was common (47.7%; HBV: 72.6%, HCV: 22.6%), a high proportion of patients (37.0%) presented with cryptogenic (unidentified) risk factors. Late-stage presentation was characteristic, evidenced by a mean tumor size of 10.0(± 4.6) cm and 63.8% of patients being BCLC stage C. 50% of cirrhotic patients were Child-Pugh B. These factors limited curative options, with resection performed in only 17.7% of the cohort, while 27.7% received TACE.
conclusionMost HCC patients in this setting present with advanced-stage disease and large tumor burdens, leading to low curative resection rates. Addressing deficiencies in specialized human resources, infrastructure, and policy gaps is critical to improving access to life-saving surgical and loco-regional interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.